Nancyclotep’s management and production teams will be present at the EANM Nuclear Medicine congress in Düsseldorf, from October 12 to 14 2018, to meet their future partners.
Previous PostNancyclotep is positioning itself to become the reference center for Vectorized Internal Radiotherapy in the Greater East region
